References
- Battifora H, McCaughey W. Tumors of the serosal membranes. Atlas of Tumor Pathology. Vol 15. Washington, DC: Armed Forces Institute of Pathology, 1995, pp. 128.
- Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260–271.
- Pavlisko EP, Sporn TA. Mesothelioma. In: Oury TD, Sporn TA, Roggli VL, ed. Pathology of asbestos-associated diseases, 3rd edn. New York, NY: Springer, 2014, pp. 81–140
- Lippmann M. Asbestos exposure indices. Environ Res 1988;46: 86–106.
- Becklake MR. On Dr. Dunnigan’s commentary linking chrysotile asbestos with mesothelioma. Am J Ind Med 1988;14:239–240.
- Churg A. Reply to Dr. Dunnigan. Chrysotile as a mesothelial carcinogen in man. Am J Ind Med 1988;14:235–238.
- Dunnigan J. Linking chrysotile asbestos with mesothelioma. Am J Ind Med 1988;14: 205–209.
- McDonald JC. Tremolite, other amphiboles, and mesothelioma. Am J Ind Med 1988;14:247–249.
- Roggli VL, Pratt PC. Amphiboles and chrysotile asbestos exposure. Am J Ind Med 1988;14:245–246.
- Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565–601.
- Roggli VL, McGavran MH, Subach J, Sybers HD, Greenberg SD. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: A study of 25 cases. Cancer 1982;50:2423–2432.
- Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos associated diseases: A study of 110 cases. Br J Ind Med 1986;43:18–28.
- Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: A light and scanning electron microscopic analysis of 18 cases. Mod Pathol 1995;8:614–621.
- Antman KH. Current concepts: Malignant mesothelioma. N Engl J Med 1980;303:200–202.
- Elmes PC, Simpson JC. The clinical aspects of mesothelioma. Q J Med 1976;45:427–449.
- Hammond EC, Selikoff IJ, Seidman H Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci, 1979;330: 473–490.
- Newhouse ML, Berry G. Predictions of mortality from mesothelial tumours in asbestos factory workers. Br J Ind Med 1976;33:147–151.
- Roggli VL, Sharma A. Analysis of tissue mineral fiber content. In: Oury TD, Sporn TA, Roggli VL, ed. Pathology of asbestos-associated diseases, 3rd edn. New York, NY: Springer, 2014, pp. 253–292.
- Roggli VL, Vollmer RT. Twenty-five years of fiber analysis: What have we learned? Hum Pathol. 2008;39:307–315.
- Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26: pp. 55–65.
- Manni ML, Oury T. Benign asbestos-related pleural disease. In: Oury TD, Sporn TA, Roggli VL, ed. Pathology of asbestos-associated diseases, 3rd edn. New York, NY: Springer, 2014, pp. 141–156.
- Sporn TA, Roggli VL. Asbestosis. In: Oury TD, Sporn TA, Roggli VL, ed. Pathology of asbestos-associated diseases, 3rd edn. New York, NY: Springer, 2014, pp. 53–80.
- Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med 2010;134:462–480.
- Husain AN, Colby T, Ordonez N, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2013;137:647–667.
- Roggli VL. Asbestos bodies and non-asbestos ferruginous bodies. In: Oury TD, Sporn TA, Roggli VL, ed. Pathology of asbestos-associated diseases, 3rd edn. New York, NY: Springer, 2014:25–52.
- Roggli VL. Mineral fiber content of lung tissue in patients with malignant mesothelioma. In: Henderson D, Shilkin K, Langlois S, ed. Malignant mesothelioma. New York: Hemisphere, 1992, pp. 201–222.
- Roggli VL, Pratt PC, Brody AR. Asbestos fiber type in malignant mesothelioma: An analytical scanning electron microscopic study of 94 cases. Am J Ind Med 1993;23:605–614.
- Klebe S, Brownlee NA, Mahar A, et al. Sarcomatoid mesothelioma: A clinical-pathologic correlation of 326 cases. Mod Pathol 2010;23:470–479.
- Pavlisko EN, Roggli VL. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic correlation of 13 cases. Am J Surg Pathol 2015;39:1568–1575.
- Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. Tremolite and mesothelioma. Ann Occup Hyg 2002;46(5):447–453.
- Dodson RF, O’Sullivan MF, Huang J, Holiday DB, Hammar SP. Asbestos in extrapulmonary sites: Omentum and mesentery. Chest 2000;117:486–493.
- Friedman GK: Clinical diagnosis of asbestos-related disease, CH 7, In: Dodson RF, Hammar SP, eds. Asbestos: Risk assessment, epidemiology, and health effects. Boca Raton: Taylor & Francis, 2006, pp. 309–380.
- McDonald AD, Case BW, Churg A, Dufresne A, Gibbs GW, Sebastien P, McDonald JC. Mesothelioma in Quebec chrysotile miners and millers: Epidemiology and aetiology. Ann Occup Hyg 1997;41:707–719.